Synthetic biology innovations need a clearer path to market
29Oct
Synthetic biology innovations need a clearer path to market


A new report from the Wilson Center’s Synthetic Biology Project highlights the need to modernize the complex and often times contradictory regulatory oversight of the synthetic biology industry. Right now, there’s a confusing mix of federal regulators (FDA, USDA and EPA) and an alphabet soup of federal statutes (TSCA, FIFRA, FFDCA, PPA) that result in some […]









Por Administrador
Administrador del Sitio
Publicado el 29 de October del 2015
publicidad
Last Comments

Recent Comments

    publicidad